Rizatriptan Benzoate Articles
Merck & Co rises 2.3% as it beats 4th quarter 2009 sales forecast, boosted by Schering-Plough
17 February 2010
USA's Consumer Reports warns pain pills can worsen headaches
8 September 2008
Tokyo pharma stocks - week to Sept 15
22 September 2003
Stock Commentary - Tokyo
8 November 2001
Tokyo pharma stocks - week to November 5
7 November 2001
Maxalt approved in EU for menstrual migraine
7 September 2000
Elan's migraine drug nears US approval
4 May 2000
Merck obtains rights to Kyorin diabetes drug
28 October 1999
FDA requests drug interaction data for Pfizer's Relpax
26 October 1999
Canada OKs Merck's Maxalt
16 September 1999
Maxalt outperforms rival triptans
1 July 1999
MSD's Maxalt effective in menstrual migraine
22 April 1999
Zeneca's fast-dissolve Zomig filed in EU
24 February 1999
MSD Launches Maxalt In The UK
9 September 1998
Merck's Maxalt Approved In USA
1 July 1998
Forecasts For Global CNS Growth
23 June 1998
Merck & Co's Rizatriptan Approved In Holland
25 February 1998
GW's Naratriptan Approved In The USA
12 February 1998
Top Pharma & Biotech Stock Picks For 1998
4 February 1998
Migraine Market Hotting Up In The USA
20 January 1998
Analysts Assess Outlook For US Drug Majors
8 January 1998
...Merck Confident It Can Hold Growth Rates
9 December 1997
New Migraine Drugs Featured At IHS Meeting
19 June 1997
Merck's New Drugs For Arthritis And Infections
27 May 1996
Showing 1-34 of 34 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
